Urinary Bladder Cancer
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography plays a role in staging muscle-invasive bladder cancer and detecting recurrent disease after radical cystectomy. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in urinary bladder cancer.